Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial.

@article{Casson1998PostmenopausalDA,
  title={Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial.},
  author={Peter R Casson and Nanette F. Santoro and Karen Elkind-Hirsch and Sandra A. Carson and Peter Hornsby and George Abraham and John E. Buster},
  journal={Fertility and sterility},
  year={1998},
  volume={70 1},
  pages={107-10}
}
OBJECTIVE To determine the effect of administering 6 months of oral postmenopausal DHEA therapy on serum DHEA, DHEAS, and T levels and on physiologic endpoints including lipoproteins and insulin-like growth factor-I (IGF-I). DESIGN Randomized, double-blind, parallel trial. SETTING Academic referral practice. PATIENT(S) Thirteen normal-weight or overweight, healthy, nonsmoking, postmenopausal women. INTERVENTION(S) Administration of oral micronized DHEA (25 mg/d). MAIN OUTCOME MEASURE… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

Similar Papers

Loading similar papers…